Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Diego Salas-Benito, Ph.D.

Concepts (64)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Diego Salas-Benito's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Diego Salas-Benito has written about over time.
Carcinoma, Non-Small-Cell Lung, 2 publications between 2016 and 2020, average publication date September 2018. CD8-Positive T-Lymphocytes, 2 publications between 2017 and 2021, average publication date March 2019. Lymphocytes, Tumor-Infiltrating, 2 publications between 2017 and 2021, average publication date March 2019. Cancer Vaccines, 1 publications between 2019 and 2019, average publication date July 2019. Gene Expression Regulation, Neoplastic, 1 publications between 2021 and 2021, average publication date January 2021. Ovarian Neoplasms, 1 publications between 2021 and 2021, average publication date January 2021. Carcinoma, Pancreatic Ductal, 2 publications between 2019 and 2024, average publication date December 2021. Neoplasms, 4 publications between 2020 and 2023, average publication date April 2022. Pancreatic Neoplasms, 3 publications between 2019 and 2024, average publication date July 2022. Immunotherapy, Adoptive, 5 publications between 2017 and 2024, average publication date September 2022. Endopeptidases, 1 publications between 2024 and 2024, average publication date April 2024. GPI-Linked Proteins, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Salas-Benito's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (64)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.